Tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate
C21H26F2N4O4 — CID 171767457
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate
Tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate (PubChem CID 171767457) has the molecular formula C21H26F2N4O4 and a molecular weight of 436.46 g/mol. Its IUPAC name is tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate |
|---|---|
| PubChem CID | 171767457 |
| Molecular Formula | C21H26F2N4O4 |
| Molecular Weight | 436.46 g/mol |
| Exact Mass | 436.19 |
| IUPAC Name | tert-butyl N-[(1S,3S)-3-[[5-[3-(difluoromethoxy)-2-oxo-1-pyridinyl]-2-pyridinyl]amino]cyclopentyl]carbamate |
| SMILES | CC(C)(C)OC(=O)N[C@H]1CC[C@H](Nc2ccc(-n3cccc(OC(F)F)c3=O)cn2)C1 |
| InChI | InChI=1S/C21H26F2N4O4/c1-21(2,3)31-20(29)26-14-7-6-13(11-14)25-17-9-8-15(12-24-17)27-10-4-5-16(18(27)28)30-19(22)23/h4-5,8-10,12-14,19H,6-7,11H2,1-3H3,(H,24,25)(H,26,29)/t13-,14-/m0/s1 |
| InChIKey | YVOIPMJWJJUXOE-KBPBESRZSA-N |
| XLogP | 3.69 |
| TPSA | 94.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.46 |
| LogP ≤ 5 | 3.69 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171767457 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.